Form 4: USANA CIO Benedict Awarded 21,775 RSUs

Sentiment:

Insider Transaction Disclosure


USANA Health Sciences' Chief Information Officer, Peter Benedict, was granted 21,775 restricted stock units, vesting over four years.

Summary

  • Peter Benedict, the Chief Information Officer of USANA Health Sciences Inc. (USNA), was granted 21,775 Restricted Stock Units (RSUs).
  • Each RSU represents a contingent right to receive one share of USNA common stock.
  • The grant occurred on February 19, 2026.
  • These RSUs will vest at 25% on each subsequent February 19th, starting from February 19, 2027.
  • Following this transaction, Peter Benedict beneficially owns a total of 42,508 derivative securities (Restricted Stock Units).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that aim to retain key talent and align management's interests with long-term company performance. It is a routine disclosure rather than a significant operational or financial announcement.

Positives

  • The grant of Restricted Stock Units to a key executive like the Chief Information Officer indicates continued commitment to executive retention and alignment of management interests with shareholder value.
  • This compensation structure incentivizes long-term performance and stability within the company's leadership.

Future Outlook

The granted Restricted Stock Units are scheduled to vest in four equal annual installments on February 19th of each year, starting in 2027, providing a clear future compensation schedule for the Chief Information Officer.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units is a standard practice in executive compensation across various industries, including health sciences. This method aligns executive incentives with long-term shareholder value by tying compensation to the company's stock performance and requiring continued service for vesting. Competitors often utilize similar equity-based compensation plans to attract and retain top talent.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) as a form of executive compensation is a widely adopted practice, comparable to compensation strategies at companies like Herbalife Nutrition Ltd. (HLF) or Nu Skin Enterprises, Inc. (NUS), which also utilize equity awards to incentivize their leadership.
  • A four-year vesting schedule, with annual installments, is a common structure designed to promote long-term retention and performance, consistent with industry benchmarks for executive equity grants.

Stakeholder Impact

  • Shareholders: The RSU grant aligns the Chief Information Officer's financial interests with the company's long-term stock performance, potentially benefiting shareholders through sustained executive motivation and retention.
  • Employees: This action reinforces the company's commitment to competitive executive compensation, which can indirectly influence overall employee morale and retention strategies.

Next Steps

  • The granted Restricted Stock Units will vest at 25% on February 19, 2027, and annually thereafter until fully vested.

Key Dates

DateDescription
02/19/2026Date of RSU grant to Peter Benedict.
02/19/2027First vesting date for 25% of the granted RSUs.
02/19/2028Second vesting date for 25% of the granted RSUs.
02/19/2029Third vesting date for 25% of the granted RSUs.
02/19/2030Fourth and final vesting date for 25% of the granted RSUs.
02/23/2026Date the Form 4 was signed by the attorney-in-fact.

Keywords

USANA Health Sciences, USNA, Restricted Stock Units, RSU grant, executive compensation, insider transaction, Form 4, Peter Benedict, Chief Information Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.